ICON Net Income 2010-2024 | ICLR
ICON annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- ICON net income for the quarter ending March 31, 2024 was $0.187B, a 60.68% increase year-over-year.
- ICON net income for the twelve months ending March 31, 2024 was $0.683B, a 33.95% increase year-over-year.
- ICON annual net income for 2023 was $0.612B, a 21.18% increase from 2022.
- ICON annual net income for 2022 was $0.505B, a 229.87% increase from 2021.
- ICON annual net income for 2021 was $0.153B, a 53.91% decline from 2020.
| ICON Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $612 |
| 2022 | $505 |
| 2021 | $153 |
| 2020 | $332 |
| 2019 | $374 |
| 2018 | $323 |
| 2017 | $281 |
| 2016 | $262 |
| 2015 | $240 |
| 2014 | $172 |
| 2013 | $103 |
| 2012 | $55 |
| 2011 | $23 |
| 2010 | $87 |
| 2009 | $94 |
| ICON Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $187 |
| 2023-12-31 | $216 |
| 2023-09-30 | $164 |
| 2023-06-30 | $116 |
| 2023-03-31 | $117 |
| 2022-12-31 | $117 |
| 2022-09-30 | $160 |
| 2022-06-30 | $116 |
| 2022-03-31 | $112 |
| 2021-12-31 | $76 |
| 2021-09-30 | $-94 |
| 2021-06-30 | $74 |
| 2021-03-31 | $97 |
| 2020-12-31 | $101 |
| 2020-09-30 | $92 |
| 2020-06-30 | $48 |
| 2020-03-31 | $92 |
| 2019-12-31 | $99 |
| 2019-09-30 | $95 |
| 2019-06-30 | $92 |
| 2019-03-31 | $88 |
| 2018-12-31 | $88 |
| 2018-09-30 | $85 |
| 2018-06-30 | $72 |
| 2018-03-31 | $78 |
| 2017-12-31 | $71 |
| 2017-09-30 | $74 |
| 2017-06-30 | $65 |
| 2017-03-31 | $71 |
| 2016-12-31 | $74 |
| 2016-09-30 | $64 |
| 2016-06-30 | $61 |
| 2016-03-31 | $63 |
| 2015-12-31 | $64 |
| 2015-09-30 | $62 |
| 2015-06-30 | $59 |
| 2015-03-31 | $56 |
| 2014-12-31 | $54 |
| 2014-09-30 | $50 |
| 2014-06-30 | $41 |
| 2014-03-31 | $36 |
| 2013-12-31 | $33 |
| 2013-09-30 | $28 |
| 2013-06-30 | $22 |
| 2013-03-31 | $19 |
| 2012-12-31 | $21 |
| 2012-09-30 | $18 |
| 2012-06-30 | $13 |
| 2012-03-31 | $9 |
| 2011-12-31 | $4 |
| 2011-09-30 | $-3 |
| 2011-06-30 | $13 |
| 2011-03-31 | $8 |
| 2010-12-31 | $22 |
| 2010-09-30 | $20 |
| 2010-06-30 | $23 |
| 2010-03-31 | $22 |
| 2009-12-31 | $31 |
| 2009-09-30 | $24 |
| 2009-06-30 | $19 |
| 2009-03-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $25.434B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| Cencora (COR) | United States | $48.051B | 19.18 |
| DiDi Global (DIDIY) | China | $24.387B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Revvity (RVTY) | United States | $12.539B | 21.83 |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.742B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.108B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |